AstraZeneca’s breast cancer drug combination fails in late-stage trial
The trial, known as CAPItello-290, was testing whether the drug combination improved overall survival in patients
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Paclitaxel
Venus Remedies gets marketing approvals from Philippines, Saudi Arabia for three drugs
While Saudi Arabia is the largest pharma market in GCC region, Philippines happens to be the second largest market in South East…
Venus Remedies gets marketing approval for six chemotherapy drugs from Philippines
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug oxaliplatin
Venus Remedies gets marketing authorisation from UK MHRA for Cisplatin
The company intends to increase sales in the UK to approximately two million euros by focusing on seven molecules which are…